Introduction
Electric and magnetic fields (EMF) are produced when electric power is generated, transmitted, and used. Worries about even if EMF could negatively affect human health were raised at the beginning by epidemiologic studies reported in the late 1970s, and since the 1980s, data's on EMF have been widely announced in the popular press. Electromagnetic fields (EMF) such as those from electric power transmission and distribution lines (50/60 Hz) have been associated with increased risk of childhood leukemia, cancer of the nervous system, lymphomas and other cancer types. At the same time humans are daily exposed to electromagnetic field (EMF) resources. In 2002, the International Agency for Research on Cancer (IARC, 2002) categorized extremely low frequency (ELF-EMF) (including the power frequencies of 50 and 60 Hz) magnetic fields as "possibly carcinogenic" [1] . Some parts of studies have marked possibly contrary effects induced by EMF [2] . On the other hand some researchers have showed beneficial effects of EMF in biological aspects [3] . [5] . In the 2008, Researchers published that Sulindac may be more effective than Celecoxib which is Celecoxib, highly selective COX-2 inhibitor, when it is combined with DMFO in FAP patients who has colectomy operation [6] . On the other hand α-lactalbumin has been used for combination therapy. α-lactalbumin is the most generous protein in human milk and is renowned as a coenzyme in lactose synthesis. Researchers have found that when α-lactalbumin and oleic acid are used together as a complex which is called as HAMLET, they have effects on tumor cell viability. This molecular complex induces apoptosis in cancer cells but normal differentiated cells are resistant to HAMLET [7] [8] [9] . Living systems are under pressure of a lot of factor, which some of these factors compels to cells to cancer formation such as air, water pollutants and electromagnetic fields. Response to cancer therapy is also dependent to environmental factors. For this reason, in this study, effects of ELF-EMF on the α-lactalbumin and sulindac treatments were investigated
Material and methods

Cell Culture
Semi-adhesive, Human Primary colon cancer cell line Colo-320 (HTL95027, Interlab Cell Line Collection, Genova, Italy) and Adhesive, Metastatic human colon cancer cell line Colo-741 (HTL95008, Interlab Cell Line Collection, Genova, Italy) were incubated in %5 CO 2 , 37 ºC, Humidified Atmosphere conditions.
Extremely
Low Frequency Electromagnetic Field ELF-EMF For generating electromagnetic field, Helmholtz coils (Leibold Elektrotechnik, Germany) and signal generator (Philiphs) equipment was used. Diameter of Helmholtz coil measured as 20 cm and distance between two coils measured as 10 cm. Configuration of field is designed by using non-pulsed alternative current at 60 Hz and 15 volt. Field that generated by method described above, was measured and characterized by 
Results
ELISA Results
There are certain implications of cellular responses influenced by EMF in vitro.
A tremendous number of cellular components, cellular signals and cellular systems can probably be affected by EMF. However, EMFs are contrary to cause DNA damage directly because it has not been showed any data like that; most studies have been developed to investigate its effect on the cellular membrane, several gene expression, and signal transduction pathways. In our study, firstly we tested cytotoxicity of combination drug treatment and EMF effect on primary, metastatic colon cancer cells and mice STO fibroblast cells as a normal cell group by ELISA. We have clearly seen that EMF treated all groups have more cytotoxic effect than other groups (Figure 3 ). Cells were cultured in 24 wells of tissue culture plate. After sub-culturing of cells, they were cultured 24 hours. Both COLO-320 and COLO-741 cells were treated with α-lactalbumin, sulindac and combined treatment (α-lactalbumin + sulindac). For control, we used untreated COLO-320, COLO-741 and STO cells. The cells from all groups were exposed to 60 Hz power line EMF for 48 hours. Every 2 hours, EMF was exposure for 15 minutes, during 48 hours, 8 exposures were applied. The TUNEL positive cells (apoptotic cells) were detected, which were identified with brown nucleus, in all groups. However, there were more apoptotic cells in COLO-320 treated with α-lactalbumin and EMF exposure applied group when we compare with other groups (Figure 4) . Apoptotic cells were less in STO cells (Figure 5, 6 ). There was some brown looking cells observed but they were death cells in the culture.
Ki-67 Immunoreactivity
Ki-67 is a cancer antigen that is found in growing and proliferating cells. The distribution of Ki-67 was also detected in all groups, but, there were more Ki-67 immunoreactivity in COLO-741 cell line which is characterized metastatic behavior ( Figure 7) . 
Discussion
Effects of electromagnetic field in normal and cancer cells are under investigation by researchers. But still there are a few studies about EMF effect combined with chemotherapeutics and other neo-adjuvant agents. Especially, in this study the behavior of primary or metastatic tumor cells may be different; therefore, the effective treatment can be important to cure for cancer. Our results suggest that combination treatment of EMF and α-lactalbumin is more effective when we compare with other groups. Svanborg and her colleagues have identified HAMLET as a new perioral agent for colon cancer prevention and treatment [10] . EMF can enhance α-lactalbumin induced apoptosis. Ki-67 immunoreactivity of COLO-741 cell line was more than other groups. This data can provide that metastatic colon cancers have high proliferative rate. This high degree of proliferation in metastatic colon cancer cells can minimize exposure of EMF. Although no change in colonic cell line proliferation, the balance between proliferation and apoptosis in the direction of increased apoptosis may be appropriate for treatment in in vitro condition; this effect may be analyzed also in vivo applications.
